Metastatic triple-negative breast cancer – current treatment strategies in the Nordics: a modified Delphi study
The high level of consensus for new treatment strategies, such as CPI and PARP-inhibitors in 1L and SG in 2L or later lines, in comparison with the limited consensus for older treatments, such as chemotherapy, may reflect the growing academic evidence for different treatment strategies. Understanding the treatment patterns across different countries contributes to gaining consensus on the upcoming therapeutic advances.
Authors
- Antonis Valachis
- Jürgen Geisler (ORCID: https://orcid.org/0000-0001-6239-3856)
- Peeter Karihtala (ORCID: https://orcid.org/0000-0003-3490-3702)
- Malgorzata Tuxen (ORCID: https://orcid.org/0009-0003-2466-0767)
Institutions
- University of Helsinki (FI)
- University of Oslo (NO)
- Örebro University (SE)
- Akershus University Hospital (NO)
- Helsinki University Hospital (FI)
- Gentofte Hospital (DK)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-03-05
- DOI
- https://doi.org/10.2340/1651-226x.2025.42733
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00